White patients more likely to receive prescriptions Among patients, 10.7% were prescribed SGLT2 inhibitors and 7.7% GLP-1 receptor agonists
Veterans Affairs databases found that GLP-1RA use was associated with reduced risks of major adverse cardiovascular events (MACE), stroke, heart failure, cardiac arrest, and thromboembolic disorders

Patients who specifically want brand-name FDA-approved GLP-1 medications (oral Wegovy pill, injectable Wegovy, Zepbound, or Ozempic) through a telehealth platform Patients who specifically want a multi-condition membership platform (Hims covers hair loss, ED, mental health, etc.) rather than a focused GLP-1 program Patients with commercial insurance they want to run through pharmacy for brand-name GLP-1 coverage Patients who value Ros broader multi-condition telehealth catalog (sexual health, dermatology, fertility, etc.) under one platform Patients comfortable with a membership-plus-medication pricing model, where the total monthly cost is higher but medication variety is broader How to switch from Ro to Cora Health Patients who want to move their GLP-1 treatment from Ro to Cora Health can generally do so without clinical interruption, though the specific steps depend on medication, dose, and state
It contributes to the formation of red blood cells and plays a role in DNA synthesis